Hypertension Management in Transition: From CKD to ESRD

Sarafidis, 2008, Hypertension awareness, treatment, and control in chronic kidney disease, Am J Med, 121, 332, 10.1016/j.amjmed.2007.11.025

Cooper, 2010, A randomized, controlled trial of early versus late initiation of dialysis, N Engl J Med, 363, 609, 10.1056/NEJMoa1000552

2014

Charytan, 2006, The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease, Kidney Int, 70, 2021, 10.1038/sj.ki.5001934

Pogue, 2009, Disparate estimates of hypertension control from ambulatory and clinic blood pressure measurements in hypertensive kidney disease, Hypertension, 53, 20, 10.1161/HYPERTENSIONAHA.108.115154

Gabbai, 2012, Relationship between ambulatory BP and clinical outcomes in patients with hypertensive CKD, Clin J Am Soc Nephrol, 7, 1770, 10.2215/CJN.11301111

Bangash, 2009, Masked hypertension and white-coat hypertension in chronic kidney disease: a meta-analysis, Clin J Am Soc Nephrol, 4, 656, 10.2215/CJN.05391008

Kuriyama, 2005, Morning blood pressure predicts hypertensive organ damage in patients with renal diseases: effect of intensive antihypertensive therapy in patients with diabetic nephropathy, Intern Med, 44, 1239, 10.2169/internalmedicine.44.1239

Alborzi, 2007, Home blood pressures are of greater prognostic value than hemodialysis unit recordings, Clin J Am Soc Nephrol, 2, 1228, 10.2215/CJN.02250507

da Silva, 2009, Home blood pressure monitoring in blood pressure control among haemodialysis patients: an open randomized clinical trial, Nephrol Dial Transplant, 24, 3805, 10.1093/ndt/gfp332

Parati, 2010, European Society of Hypertension practice guidelines for home blood pressure monitoring, J Hum Hypertens, 24, 779, 10.1038/jhh.2010.54

Niiranen, 2013, Outcome-driven thresholds for home blood pressure measurement: international database of home blood pressure in relation to cardiovascular outcome, Hypertension, 61, 27, 10.1161/HYPERTENSIONAHA.111.00100

Berl, 2005, Impact of achieved blood pressure on cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial, J Am Soc Nephrol, 16, 2170, 10.1681/ASN.2004090763

Appel, 2010, Intensive blood-pressure control in hypertensive chronic kidney disease, N Engl J Med, 363, 918, 10.1056/NEJMoa0910975

Peixoto, 2010, Blood pressure management in hemodialysis: what have we learned?, Curr Opin Nephrol Hypertens, 19, 561, 10.1097/MNH.0b013e32833f0d82

Kovesdy, 2013, Blood pressure and mortality in U.S. veterans with chronic kidney disease: a cohort study, Ann Intern Med, 159, 233, 10.7326/0003-4819-159-4-201308200-00004

Ku, 2015, Association between strict blood pressure control during chronic kidney disease and lower mortality after onset of end-stage renal disease, Kidney Int, 87, 1055, 10.1038/ki.2014.376

Agarwal, 2005, Hypertension and survival in chronic hemodialysis patients—past lessons and future opportunities, Kidney Int, 67, 1, 10.1111/j.1523-1755.2005.00050.x

Stidley, 2006, Changing relationship of blood pressure with mortality over time among hemodialysis patients, J Am Soc Nephrol, 17, 513, 10.1681/ASN.2004110921

Agarwal, 2009, Cardiovascular protection with antihypertensive drugs in dialysis patients: systematic review and meta-analysis, Hypertension, 53, 860, 10.1161/HYPERTENSIONAHA.108.128116

Heerspink, 2009, Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials, Lancet, 373, 1009, 10.1016/S0140-6736(09)60212-9

Merrill, 1964, Mechanisms of hypertension in renoprival man, Can Med Assoc J, 90, 328

He, 2013, Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials, BMJ, 346, f1325, 10.1136/bmj.f1325

Pimenta, 2009, Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial, Hypertension, 54, 475, 10.1161/HYPERTENSIONAHA.109.131235

Slagman, 2011, Moderate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: randomised controlled trial, BMJ, 343, d4366, 10.1136/bmj.d4366

Davies, 2014, The role of bioimpedance and biomarkers in helping to aid clinical decision-making of volume assessments in dialysis patients, Kidney Int, 86, 489, 10.1038/ki.2014.207

Covic, 2014, Routine bioimpedance-derived volume assessment for all hypertensives: a new paradigm, Am J Nephrol, 40, 434, 10.1159/000369218

Taler, 2002, Resistant hypertension: comparing hemodynamic management to specialist care, Hypertension, 39, 982, 10.1161/01.HYP.0000016176.16042.2F

Jentzer, 2010, Combination of loop diuretics with thiazide-type diuretics in heart failure, J Am Coll Cardiol, 56, 1527, 10.1016/j.jacc.2010.06.034

Fliser, 1994, Coadministration of thiazides increases the efficacy of loop diuretics even in patients with advanced renal failure, Kidney Int, 46, 482, 10.1038/ki.1994.298

Knauf, 1995, Diuretic effectiveness of hydrochlorothiazide and furosemide alone and in combination in chronic renal failure, J Cardiovasc Pharmacol, 26, 394, 10.1097/00005344-199509000-00008

Dussol, 2005, A randomized trial of furosemide vs hydrochlorothiazide in patients with chronic renal failure and hypertension, Nephrol Dial Transplant, 20, 349, 10.1093/ndt/gfh650

Dussol, 2012, A pilot study comparing furosemide and hydrochlorothiazide in patients with hypertension and stage 4 or 5 chronic kidney disease, J Clin Hypertens (Greenwich), 14, 32, 10.1111/j.1751-7176.2011.00564.x

Agarwal, 2014, Chlorthalidone for poorly controlled hypertension in chronic kidney disease: an interventional pilot study, Am J Nephrol, 39, 171, 10.1159/000358603

Hou, 2006, Efficacy and safety of benazepril for advanced chronic renal insufficiency, N Engl J Med, 354, 131, 10.1056/NEJMoa053107

Kendrick, 2010, Strategies for improving long-term survival in peritoneal dialysis patients, Clin J Am Soc Nephrol, 5, 1123, 10.2215/CJN.04300709

Akbari, 2009, Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in peritoneal dialysis: systematic review and meta-analysis of randomized controlled trials, Perit Dial Int, 29, 554, 10.1177/089686080902900514

Fang, 2008, Use of ACE inhibitors or angiotensin receptor blockers and survival in patients on peritoneal dialysis, Nephrol Dial Transplant, 23, 3704, 10.1093/ndt/gfn321

Takahashi, 2006, Candesartan, an angiotensin II type-1 receptor blocker, reduces cardiovascular events in patients on chronic haemodialysis—a randomized study, Nephrol Dial Transplant, 21, 2507, 10.1093/ndt/gfl293

Iseki, 2013, Effects of angiotensin receptor blockade (ARB) on mortality and cardiovascular outcomes in patients with long-term haemodialysis: a randomized controlled trial, Nephrol Dial Transplant, 28, 1579, 10.1093/ndt/gfs590

Agarwal, 2014, Hypertension in hemodialysis patients treated with atenolol or lisinopril: a randomized controlled trial, Nephrol Dial Transplant, 29, 672, 10.1093/ndt/gft515

Cice, 2003, Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy: a prospective, placebo-controlled trial, J Am Coll Cardiol, 41, 1438, 10.1016/S0735-1097(03)00241-9

Bakris, 2004, Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and underhypertension: a randomized controlled trial, JAMA, 292, 2227, 10.1001/jama.292.18.2227

Agarwal, 1999, Supervised atenolol therapy in the management of hemodialysis hypertension, Kidney Int, 55, 1528, 10.1046/j.1523-1755.1999.00359.x

Weir, 2014, Beta-blocker dialyzability and mortality in older patients receiving hemodialysis, J Am Soc Nephrol, 26, 987, 10.1681/ASN.2014040324

Lewis, 2001, Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes, N Engl J Med, 345, 851, 10.1056/NEJMoa011303

Bakris, 1998, Effects of an ACE inhibitor/calcium antagonist combination on proteinuria in diabetic nephropathy, Kidney Int, 54, 1283, 10.1046/j.1523-1755.1998.00083.x

Smith, 1998, Differential effects of calcium channel blockers on size selectivity of proteinuria in diabetic glomerulopathy, Kidney Int, 54, 889, 10.1046/j.1523-1755.1998.00055.x

Bakris, 2010, Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial, Lancet, 375, 1173, 10.1016/S0140-6736(09)62100-0

Tepel, 2008, Effect of amlodipine on cardiovascular events in hypertensive haemodialysis patients, Nephrol Dial Transplant, 23, 3605, 10.1093/ndt/gfn304

Einhorn, 2009, The frequency of hyperkalemia and its significance in chronic kidney disease, Arch Intern Med, 169, 1156, 10.1001/archinternmed.2009.132

Navaneethan, 2009, Aldosterone antagonists for preventing the progression of chronic kidney disease: a systematic review and meta-analysis, Clin J Am Soc Nephrol, 4, 542, 10.2215/CJN.04750908

Jain, 2009, Mineralocorticoid receptor blockers and chronic kidney disease, Clin J Am Soc Nephrol, 4, 1685, 10.2215/CJN.01340209

Matsumoto, 2014, Spironolactone reduces cardiovascular and cerebrovascular morbidity and mortality in hemodialysis patients, J Am Coll Cardiol, 63, 528, 10.1016/j.jacc.2013.09.056

Vaclavik, 2011, Addition of spironolactone in patients with resistant arterial hypertension (ASPIRANT): a randomized, double-blind, placebo-controlled trial, Hypertension, 57, 1069, 10.1161/HYPERTENSIONAHA.111.169961

Pisoni, 2012, Long-term effects of aldosterone blockade in resistant hypertension associated with chronic kidney disease, J Hum Hypertens, 26, 502, 10.1038/jhh.2011.60

Khosla, 2009, Predictors of hyperkalemia risk following hypertension control with aldosterone blockade, Am J Nephrol, 30, 418, 10.1159/000237742